Our phopho-western blot data support that activating EphB4 while simultaneously avoiding activation of EFNB2 using various therapeutic strategies such as the EFNB2-Fc-His plasmid provides maximal benefit to reducing local tumor growth and distant metastases. The gene discussed is EFNB2; the disease is neoplasm.